The enrichment of the CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 gene set (Figure 2A) with a role in resistance of breast cancer to endocrine therapy [46] indicates differential expression of CNTN1 and the LE genes in CRPCs. This evidence concerns the gene CNTN1 and breast carcinoma.